Pacific Biosciences of California CEO Michael Hunkapiller's 2018 pay rises 20% to $1.6M

Pacific Biosciences of California reports 2018 executive compensation

By ExecPay News

Published: April 29, 2019

Pacific Biosciences of California reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, five executives at Pacific Biosciences of California received on average a compensation package of $925K, a 8% increase compared to previous year.
Average pay of disclosed executives at Pacific Biosciences of California
Michael Hunkapiller, Chief Executive Officer, received $1.6M in total, which increased by 20% compared to 2017. 64% of Hunkapiller's compensation, or $1M, was in bonus. Hunkapiller also received $153K in option awards, $1 in salary, as well as $427K in stock awards.
For fiscal year 2018, the median employee pay was $166,966 at Pacific Biosciences of California. Therefore, the ratio of Michael Hunkapiller's pay to the median employee pay was 10 to one.
Susan Barnes, Chief Financial Officer, received a compensation package of $1.1M, which increased by 34% compared to previous year. 55% of the compensation package, or $618K, was in bonus.
Kathy Ordoñez, Chief Commercial Officer and member of the Board of Directors, earned $678K in 2018, a 2% decrease compared to previous year.
Michael Phillips, Senior Vice President of Research and Development, received $617K in 2018, which decreases by 11% compared to 2017.
Kevin Corcoran, Senior Vice President of Market Development, earned $595K in 2018, a 15% decrease compared to previous year.

Related executives

Michael Hunkapiller

Pacific Biosciences of California

Chief Executive Officer

Susan Barnes

Pacific Biosciences of California

Chief Financial Officer

Kathy Ordoñez

Pacific Biosciences of California

Chief Commercial Officer and member of the Board of Directors

Michael Phillips

Pacific Biosciences of California

Former Senior Vice President of Research and Development

Kevin Corcoran

Pacific Biosciences of California

Senior Vice President of Market Development

You may also like

Source: SEC filing on April 29, 2019.